BioSpace News Archive

Policy

Teva Canada Announces the Approval of TRUXIMA™, the first biosimilar to RITUXAN® in Canada for the Treatment of Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia and Rheumatoid Arthritis

Teva Canada Innovation, G.P.-.S.E.N.C. announces that Health Canada has granted a notice of compliance1 for TRUXIMA™, the first biosimilar to RITUXAN®2 in Canada for the treatment of adult patients in: Non-Hodgkin’s Lymphoma, Chronic Lymphocytic Leukemia and Rheumatoid Arthritis.

April 10, 2019
·
6 min read
Business

The Government of Equatorial Guinea, US Energy Companies, and Sanaria Sign Agreements to Extend Support for Clinical Development of PfSPZ Vaccine for Malaria and a Pathway Towards Malaria Elimination on Bioko Island

Sanaria Inc. and the Government of Equatorial Guinea last week signed an agreement that continues their joint commitment to develop Sanaria® PfSPZ Vaccine as a tool for malaria elimination.

April 10, 2019
·
4 min read
Business

J.D. Power Hires Trusted Executive to Accelerate Company Growth in Healthcare Industry

James Beem Becomes Managing Director of Global Healthcare Intelligence Division

April 10, 2019
·
2 min read
Biotech Beach

OncoSec Announces New Technology to Treat Deep Visceral Lesions with IL-12

Company Published White Paper titled, “Parachuting Behind Enemy Lines: OncoSec’s Attack on Visceral Tumors via Its New Visceral Lesion Applicator (VLA)”

April 10, 2019
·
4 min read
Drug Development

FDA Expands Real-World Evidence Partnership with Brigham and Women’s Hospital and Aetion

RCT DUPLICATE adds new studies to inform FDA - the first to use real-world evidence to predict treatment safety and efficacy

April 10, 2019
·
3 min read
Business

Castlight Health to Announce First Quarter 2019 Results

At 5:00 p.m. Eastern Time (ET), senior management will host a conference call to review the Company’s financial performance.

April 10, 2019
·
1 min read
Teva Signs New $2.3 Billion Syndicated Revolving Credit Facility

Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announced today that it has entered into a new $2.3 billion unsecured revolving credit facility, which replaces its existing $3.0 billion credit facility.

April 10, 2019
·
6 min read
Genetown

EdiGENE Raises $15 Million in Series B Funding

EdiGENE, an emerging biotechnology company developing new CRISPR based therapies for treatment of genetic disorders, announced that it has raised 1.6 Billion-yen as the first tranche of Series B round.

April 10, 2019
·
2 min read
New study exposes need for better management of anaemia

A large study just published in the journal Anaesthesia raises important questions about the way anaemia is currently managed in surgical patients.

April 10, 2019
·
3 min read
Business

Accelerate Learning CEO Vernon Johnson Named EdTech Visionary Leader for 2019

The EdTech Awards 2019 also recognizes Accelerate Learning and its solutions as finalists in three other categories

April 10, 2019
·
2 min read